Oxler Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Oxler Private Wealth’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,231	Closed	-$237K	–	84
2024 Q1	$237K	Sell	8,231 -7,743	-48%	-$233K	0.09%	84
2023 Q4	$524K	Sell	15,974 -4,434	-22%	-$121K	0.43%	40
2023 Q3	$569K	Sell	20,408 -1,758	-8%	-$57.5K	0.29%	66
2023 Q2	$756K	Hold	22,166	–	–	0.36%	59
2023 Q1	$667K	Sell	22,166 -160	-0.7%	-$4.96K	0.33%	62
2022 Q4	$630K	Buy	22,326 +17,175	+333%	+$545K	0.34%	62
2022 Q3	$746K	Sell	5,151 -17,406	-77%	-$639K	0.42%	57
2022 Q2	$710K	Hold	22,557	–	–	0.34%	67
2022 Q1	$1.04M	Buy	+22,557	New	+$1.08M	0.47%	57

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Oxler Private Wealth's ARKG Position: Q2 2024 in Review

Oxler Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 8,231 shares — an estimated $237K sold.

Oxler Private Wealth first reported a position in ARKG in Q1 2022 and held it in 9 quarters. The position peaked at $1.04M in Q1 2022. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

Oxler Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
Oxler Private Wealth sold 8,231 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $237K.
Oxler Private Wealth first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 9 quarters.
Oxler Private Wealth's ARK Genomic Revolution ETF position peaked at $1.04M in Q1 2022.
261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Oxler Private Wealth's 13F filing for Q2 2024, filed 30 Jul 2024.